Organic Active Ingredients TRIZ Cases

Optimized cyclopenta pyrazole derivatives selectively inhibit aldosterone synthase while preserving cortisol and testosterone production.

Tricyclic pyridone compounds selectively inhibit the V617F variant of JAK2 while preserving essential wild-type functions.

Novel indazole compounds act as 5-HT4 receptor agonists to address unmet needs in treating Alzheimer's disease and cognitive decline.

A dynamic dosing regimen adjusts steroid doses based on individual hormone levels using a CRF1 antagonist to normalize treatment.

Combining naltrexone with ibuprofen creates a synergistic pharmaceutical composition that enhances analgesic efficacy through dual pathway inhibition.

A base-catalyzed condensation reaction forms thiazoline rings to enable scalable production of ITE analogs.

Buffering agents stabilize the microenvironment of a mesalamine tablet, preventing premature drug release under accelerated storage conditions.

Polycaprolactone capsules with nano-pores absorb antibodies internally and desorb them externally, eliminating frequent injections and surgical removal.

N-1 triazole substituted imidazoquinoline compounds induce cytokine biosynthesis to modulate the immune response.

R enantiomer of DOTAP activates dendritic cells to induce tumor regression, overcoming weak cell-mediated immunity from traditional adjuvants.

Topical 20(R)-ginsenoside Rg3 overcomes poor oral absorption and blood-brain barrier limits by leveraging lymphatic pathways to reduce beta-amyloid content.

Incorporating non-canonical nucleotides into synthetic RNA molecules to achieve sustained protein expression.

A probiotic composition comprising Lactobacillus gasseri, fermentum, and rhamnosus regulates gut flora to promote weight reduction.

Gold nanoparticles functionalized with RNA oligonucleotides resist chemical degradation to maintain gene knockdown activity without transfection agents.

Melt-extruding ARN-509 with poly(meth)acrylate copolymers creates a stable solid dispersion that eliminates cold chain storage requirements.

Cyclic alkylamine compounds disrupt the MDM2-p53 interaction, restoring p53-mediated apoptosis and sensitizing tumors to chemotherapy.

Replacing chromatography with crystallization and filtration eliminates scale-up bottlenecks while maintaining high purity levels.

Heterocyclic compounds inhibit cell proliferation by disrupting bipolar mitotic spindle formation.

Formula I compounds resolve therapeutic reliability gaps by inhibiting multiple kinases simultaneously.

A phlorotannin fraction from brown algae dedifferentiates mesenchymal stem cells into induced pluripotent stem cells.

Nebulized pirfenidone formulations target lung epithelium, reducing systemic exposure and gastrointestinal side effects.

Administering anti-HER2 antibody-drug conjugates alongside RASG12C inhibitors reduces dose-dependent toxicity while improving therapeutic durability.

Combining PEG-modified IL-2 conjugates with cetuximab targets head and neck squamous cell carcinoma through synergistic immune activation.

Formula I compounds inhibit lysine gingipain via covalent bonding, preventing cell death and inflammation.

A recombinant vector integrates a trans-splicing ribozyme with microRNA-122a targeting sequences to drive targeted gene expression in hepatocellular carcinoma cells.

Administers AMD3100 and Tacrolimus at sub-immunosuppressive doses to down-regulate inflammation while up-regulating antiviral responses.

Targeting TrkA kinase isolates pain relief from opioid addiction and respiratory depression risks.

Localized injection of sustained release formulation reduces prostate size while minimizing systemic drug exposure and sexual dysfunction side effects.

CTRP12 adipokine activates PI3K-Akt signaling to lower blood glucose and improve insulin sensitivity in type 2 diabetes.

MDPX-V2021 blocks SARS-CoV-2 replication by inhibiting the post-translational glycosylation stage through alpha-glucosidase antagonism.

Stability-improving additives in a guanfacine hydrochloride preparation suppress hydrolysis-related impurity growth by controlling the microenvironment pH.

Fasudil inhibits the Rho/ROCK pathway to restore retinal capillary perfusion, addressing macular ischemia caused by inadequate barrier function.

Converting the unstable free base into crystalline succinate and hydrochloride salts eliminates gumming during isolation and ensures thermal stability.

A disulfiram derivative inhibits the interaction between FROUNT protein and chemokine receptors CCR2 or CCR5.

Albumin-bound nanoparticle complexes deliver chemotherapeutic agents to tumor sites using sub-therapeutic antibody pretreatment.

Dietary osteopontin supplementation enhances immune defense in infants by promoting appropriate T cell responses and reducing airway inflammation.

Combining clusterin inhibitor with EGFR inhibitor restores cancer cell sensitivity to treatment.

2,3,5-trimethyl-6-nonylcyclohexa-2,5-dione overcomes inadequate brain penetration of conventional compounds by optimizing lipophilicity.

Crystallizing halobetasol propionate from non-toxic ethanol solvents achieves 99.8% purity and 95% yield, replacing toxic methylene chloride processes.

Ionic polymer dispersion keeps poorly water-soluble drugs in an amorphous state, resolving the contradiction between physical stability and dissolution rate.

Propionate inulin ester improves insulin sensitivity and promotes weight loss without adverse side effects through localized gut fermentation.

Thiazoline compounds modulate calcium release by binding to cellular proteins like G-protein receptors.

A pharmaceutical composition combining immediate release oxybutynin with delayed onset pilocarpine to reduce excessive sweating.

CRISPR-GNDM system targets MYD88 regulatory regions to suppress gene expression, resolving ineffective small molecule targeting of inflammatory pathways.

Oral or topical substituted aromatic compounds reduce toxicity while treating pulmonary, liver, and skin fibrosis.

Replacing invasive probes, ultrasound thermometry monitors tumor heat distribution while nanocarriers enable targeted drug release through acoustic cavitation.

A nanoparticle complex bonds a tube-shaped lipid structure to improve cellular uptake in spheroid-type tumor cells while maintaining high stability.

UV crosslinking and biotinylated antisense probes capture coronavirus RNA interactomes to reveal key host proteins.

Molten wax and disintegrant mixing creates erodible granules that maintain consistent drug release independent of gastrointestinal pH variations.

Chemokine receptor antagonists block fibrocyte migration to address COPD mortality risks that current symptom management fails to resolve.

A healing clay and alginic acid composition forms a protective foam barrier to neutralize stomach acid.

Neutralizing gastric acid with antacids prevents proton pump inhibitor decomposition, resolving stability and onset time trade-offs.

Synthetic polynucleotides induce exon skipping in pre-mRNA, restoring protein function lost by CEP290 genetic variants.

Hydrophilic HASA-gel matrix retains moisture to prevent rapid drying, extending therapeutic effectiveness of topical homeopathic treatments.

SSR3 expression levels predict paclitaxel susceptibility, resolving unpredictable tumor heterogeneity.

Novel piperidine derivatives inhibit human CGRP receptors with high binding affinity, resolving species-specific efficacy gaps in migraine treatment.

Nor-ursodeoxycholic acid reduces atherosclerotic plaque size and hepatic triglyceride levels, addressing arteriosclerosis without statin side effects.

Specific cyclic pantetheine derivatives treat CoA deficiencies by boosting acetyl-CoA production, mitigating hypoglycemia and liver dysfunction.

A bivalent compound links two BET inhibitor moieties via a spacer to enhance inhibitory activity.

Brilacidin and delparantag suppress pro-inflammatory cytokines via phosphodiesterase inhibition, avoiding steroid side effects.

A microencapsulated beta-alanine preparation uses a fatty acid glyceride and phospholipid wall to control release kinetics.

Sphingosine-1-phosphate modulates amyloid beta peptide vaccination to suppress inflammatory reactions while reducing pathological deposits.

Replacing the phenyl ring with pyridine overcomes T790M mutation resistance while maintaining high selectivity.

Formula II pyrazol-phenol compounds inhibit the BRM protein, overcoming insufficient activity in BRG1-deficient cancer treatments.

A DNA aptamer design substitutes internal hairpins with mini-hairpin structures to enhance molecular stability.

Multisubstituted halogenopyrazoles inhibit thrombin to overcome bleeding risks and administration constraints of existing anticoagulants.

An anhydrous hypochlorite lubricant formulation resists Candida species via oxidation, preventing vaginal itching without cytotoxicity to healthy tissues.

Liposomes deliver N-(2-aminoethyl) ethanolamine to skin tissue, altering collagen production and matrix metabolism while preventing dermatitis.

A small molecule inhibitor blocks dual specificity phosphatase 6 to modulate fibroblast growth factor signaling in zebrafish embryos.

A chiral (R)-enantiomer compound selectively inhibits aldosterone synthase while minimizing aromatase activity.

Segments cancer treatment by delivering antineoplastic particles locally and immunotherapeutic agents systemically, reducing toxicity while enhancing efficacy.

Adjusting formulation pH via deacidifying buffers stabilizes Poly(I:C) microparticles, preventing aggregation during large-volume parenteral administration.

Ion exchange chromatography separates therapeutic polyphenols from hygroscopic carbohydrates in molasses, enabling low glycemic index food products.

Oligonucleotide inhibitors lower miR-210 activity, decreasing pro-inflammatory cytokine release and improving survival rates during severe sepsis.

Electrostatic bonding links mutable collagenous tissue to chitosan, resolving mechanical strength and antimicrobial activity trade-offs.

Mannitol mediates stability while basifying agents improve absorption, resolving the trade-off between chemical stability and dissolution speed.

Acrylic adhesive patch delivers rupatadine through skin using solubilizers and surfactants to bypass first pass effect.

Optimized linkers enable high-density payload loading on exosomes, resolving the trade-off between therapeutic efficacy and systemic toxicity.

Continuous heterotrophic fermentation sustains diatom log-phase growth, resolving low volumetric productivity trade-offs inherent in batch processes.

Substituted 4H-pyrrolo[3,2-c]pyridin-4-one compounds target exon 20 insertion and C797S mutations while sparing wild-type EGFR to reduce adverse events.

Thiazolyl compounds inhibit Src family kinases to induce apoptosis in malignant blood cells, addressing insufficient efficacy of existing kinase inhibitors.

Fused bicyclic derivatives antagonize ATP at the P2X7 receptor, resolving treatment gaps for neurodegenerative disorders.

Reverse osmosis and electrodialysis isolate active fractions to treat drug-resistant Helicobacter pylori infections.

Oligomeric pentaerythritol initiates ethylene oxide polymerization to form multi-arm polyethylene glycol with controlled molecular weight distribution.

Pediococcus acidilactici strain NRRL B-50517 withstands elevated temperatures and low pH environments while maintaining viability.

Carbonyl diimidazole replaces thionyl chloride to activate carboxylic acids, eliminating toxic gas generation during amidation.

Controlling citric acid particle size and adding alpha-tocopherol eliminates surface dimples while maintaining stability under high humidity storage conditions.

Combining an anti-IL-6R antibody with methotrexate reduces DAS28-ESR scores in rheumatoid arthritis patients who do not respond to Janus kinase inhibitors.

A trivalent antibody construct merges anti-CD74 and anti-CD20 specificities into a single stable complex via the dock-and-lock technique.

A siosome carrier system delivers therapeutic agents into target cells using covalently linked cationic lipids and PEGylated organosilicon compounds.

Amide-based integrin activators enhance T-cell binding affinity and tumor infiltration, resolving low anti-cancer efficacy in solid tumors.

Fucosylated oligosaccharides modulate infant immune systems to prevent allergies, addressing maternal deficiency gaps that limit conventional formula efficacy.

Compacting surface-reacted calcium carbonate with active ingredients using a roller compactor produces granules with improved flowability.